Thierry André

机构：Centre National de la Recherche Scientifique, Centrale Lyon ENISE, Inserm, Sorbonne Université, Assistance Publique – Hôpitaux de Paris, Hôpital Saint-Antoine, Centre de Recherche Saint-Antoine · ORCID：0000-0002-5103-7095

发表论文 1090 篇 · 总被引 59548 次 · h-index 102

代表论文

• Pembrolizumab Plus Chemotherapy Versus Chemotherapy as Perioperative Therapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer: Final Analysis of the Randomized, Phase III KEYNOTE-585 Study (2025 · Journal of Clinical Oncology · 被引 39)
• Neoadjuvant CTLA-4/PD-(L)1 Blockade Versus Surgery +/− Chemotherapy in Deficient Mismatch Repair/Microsatellite Instability–High Resectable Gastroesophageal Adenocarcinoma: Individual Patient Data Pooled Analysis (2025 · Journal of Clinical Oncology · 被引 12)
• Occurrence of dMMR/MSI-H tumor during follow-up in Lynch syndrome patients treated with immune checkpoint inhibitors for metastatic digestive cancer between 2015 and 2024: a retrospective analysis of a monocentric prospective cohort study (2025 · ESMO Open · 被引 6)
• First-line PD-1 +/- CTLA-4 blockade in patients with deficient mismatch repair and/or microsatellite instability-high metastatic colorectal cancer (2025 · The Oncologist · 被引 6)
• Inflammation and mutational burden differentially associated with nivolumab or ipilimumab combination efficacy in colorectal cancer (2025 · Nature Communications · 被引 5)
• Impact of RAS / BRAF V600E Mutations on the Tumor Immune Microenvironment in Mismatch Repair–Deficient/Microsatellite Instability Colorectal Cancers (2025 · Clinical Cancer Research · 被引 4)